TrialEuropean journal of clinical pharmacology2013

CYP2C9 and VKORC1 polymorphisms influence warfarin dose variability in patients on long-term anticoagulation.

Paulo Caleb Junior Lima Santos et al.PubMed ↗Publisher ↗

No numbers read from the abstract.